Advantages | Buprenorphine (245 responses) | n (%) | Methadone (238 responses) | n (%) | Naltrexone (234 responses) | n (%) | Total (250 responses) |
---|---|---|---|---|---|---|---|
“No advantages” | - | 1 (0%) | - | 7 (3%) | - | 0 (0%) | 7 (3%) |
Reduces urges to use | “Curbs cravings while preserving general functioning.” | 76 (31%) | “Helps reduce cravings” | 60 (25%) | “Helping with triggers and cravings.” | 57 (24%) | 104 (42%) |
Reduce use of illicit opioids/substances | “The advantages are the patient will decrease their craving for their particular substance, and then possibly stop using their substance of choice.” | 53 (22%) | “[Helps] stay away from illegal usage” | 52 (22%) | “Can help to reduce likelihood of use after treatment… No withdrawal to come off medication.” | 38 (16%) | 92 (37%) |
Flexible/convenient | “Not having to go to a clinic every day to get dosed and also being able to travel out of town for a period of time because you have your doses with you.” | 11 (4%) | - | 0 (0%) | “It is a once-a-month injection allowing members to have more freedom.” | 57 (24%) | 62 (25%) |
Supports recovery lifestyle | “The chance to chemically trick your body enabling you the time to change habits, though processes and obtain clean time from the substance you are desperately trying to avoid.” | 26 (11%) | “This form of [medication assisted treatment] could support their efforts to manage their recovery management and stay away from negative people, places, and illicit activities.” | 37 (16%) | “Of course this can offer many patients an ability to function and live a productive life.” | 14 (6%) | 51 (20%) |
Reduces withdrawal symptoms | “It reduces severe opiate withdrawal symptoms, such as perspiration, nausea, anxiety, difficulty sleeping, chills, sensitivity to the light, and stomach pain.” | 28 (11%) | “Clients can manage their cravings and withdrawal symptoms with methadone use, been used for a long time as a substitute treatment.” | 28 (12%) | “Activat[es] to relieve craving and withdrawal it acts as a blocker, preventing other opioids from having any effect.” | 9 (4%) | 42 (17%) |